Revolutionizing Multiple Myeloma Treatment with New Therapy
Professor Julie O'Neal's team found that a long-acting IL-7 helped CAR-iNKT immune cells expand, persist and control multiple myeloma better in mice, with signs of lower inflammatory risk.
Features based on peer-reviewed papers published in Blood Advances.
Professor Julie O'Neal's team found that a long-acting IL-7 helped CAR-iNKT immune cells expand, persist and control multiple myeloma better in mice, with signs of lower inflammatory risk.
Dr. Benjamin Djulbegovic and Dr. Charles Greenberg argue that unnecessary referrals to haematologists, driven partly by time pressure, fragment care and lengthen waits for patients.